AstraZeneca PLC expected to post earnings of $1.15 a share - Earnings Preview
AstraZeneca PLC
AZN, AZN is expected to show a rise in quarterly revenue when it reports results on November 6 for the period ending September 30 2025The Cambridge United Kingdom-based company is expected to report a 9.0% increase in revenue to $14.78 billion from $13.57 billion a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
LSEG's mean analyst estimate for AstraZeneca PLC is for earnings of $1.15 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for AstraZeneca PLC is $93.34, about 12.4% above its last closing price of $81.72
